Combination immunotherapy holds promise as improved ovarian cancer treatment – The Hub at Johns Hopkins
The Hub at Johns Hopkins |
Combination immunotherapy holds promise as improved ovarian cancer treatment
The Hub at Johns Hopkins Researchers from the Johns Hopkins Kimmel Cancer Center have demonstrated that mice with ovarian cancer that were treated with combination immunotherapy—receiving drugs to reactivate dormant genes along with other drugs that activate the immune system … |
